Skip to content

Trial of isometric exercise to lower blood pressure

Randomised controlled effectiveness trial (RCT) of isometric exercise (IE) in adults with stage 1 and 2 hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN28188474
Enrollment
542
Registered
2025-04-11
Start date
2025-04-14
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage 1 and 2 hypertension Circulatory System

Interventions

This study is a multi-centre randomised controlled trial (RCT) of an isometric exercise intervention for participants with Stage 1 and Stage 2 hypertension. The design follows an effectiveness-impleme

Sponsors

East Kent Hospitals University NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participants with Stage 1 or 2 Hypertension who have uncomplicated hypertension and may be on a single anti-hypertensive agent who are: 1. Aged 18+ years old 2. Stage 1 or 2 hypertension (=140/90 -179/119 mmHg) that has been diagnosed by a health care professional and confirmed by a GP 3. Able to undertake an IE intervention 4. Able to self-monitor BP 5. Prescribed no more than 1 anti-hypertensive agent

Exclusion criteria

Exclusion criteria: 1. Alteration to antihypertensive medications (either dose or number of medications) within 6 weeks prior to screening 2. Receiving a ß-blocker 3. Averaged home SBP <120 mmHg following 3 days screening 4. Ischaemic heart disease, stroke or transient ischaemic attack in the past 3 months 5. Moderate or severe valvular heart disease, atrial or ventricular arrhythmia, congenital or inherited heart condition 6. Pregnancy or actively trying to conceive 7. Enrolled in CTIMP/device/another interventional study of BP. 8. Any condition that would be made worse by doing the wall squat exercise

Design outcomes

Primary

MeasureTime frame
Average home systolic blood pressure (SBP) measured using a home BP monitor, change from baseline to 3 months

Secondary

MeasureTime frame
1. Proportion of participants with home average BP of =135/85 mmHg measured using a home BP monitor at 4 weeks, 3 months, 6 months and 12 months. 2. Average Home Systolic blood pressure measured using a home BP monitor, change from baseline to 4 weeks. 3. Average Home Systolic blood pressure measured using a home BP monitor, change from baseline to 6 months. 4. Average Home Systolic blood pressure measured using a home BP monitor, change from baseline to 12 months in the IE group. 5. Average Home Diastolic blood pressure measured using a home BP monitor, change from baseline to 4 weeks. 6. Average Home Diastolic blood pressure measured using a home BP monitor, change from baseline to 3 months. 7. Average Home Diastolic blood pressure measured using a home BP monitor, change from baseline to 6 months. 8. Average Home Diastolic blood pressure measured using a home BP monitor, change from baseline to 12 months in the IE group. 9. Fidelity of intervention using the number of perceived exertion scores within the range 7-9 during the last exercise bouts collected using participant-reported data in the first week of intervention in the first 50 IE participants. 10. Participant experience (acceptability, adoption and feasibility) of intervention measured using an IE experience questionnaire, considering barriers and facilitators using focus groups at 4 weeks. 11. Change from baseline in the use and cost of NHS services by participants in both groups, measured using the Health Resources Utilisation Questionnaire at 3 months and 6 months. 12. Change from baseline in Quality of Life in both groups measured using the EQ-5D-5L questionnaire at 3 months and 6 months. 13. Total of equipment, supplies and staff costs measured using internal cost records and staff time and hourly rate records as total cost of the intervention, using costing analysis throughout the study. 14. Total of equipment, supplies and staff costs divided by the number of participants measured using in

Countries

England, United Kingdom, Wales

Contacts

Public ContactEllie Santer
e.santer@kent.ac.uk+44 (0)1227 816439

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 30, 2026